A new study from the Knight Initiative for Brain Resilience researchers may help explain an enduring mystery about ...

A drug candidate found to protect nerve cells damaged by motor neuron disease (MND), could offer new hope to people living with the devastating condition. Researchers at the University of Sheffield's ...

A new medicine, discovered by scientists, protects nerve cells damaged by motor neurone disease (MND), offering hope of substantially slowing the progression of "one of the cruellest diseases".

We report an important role for microglia in regulating neuroplasticity within phrenic motor neurons. Brief episodes of low oxygen (acute intermittent hypoxia; AIH) elicit a form of respiratory motor ...

Mutations in two highly related chromatin-remodeling complexes, BRG1/BRM-associated factor (BAF) and Polybromo-associated BAF (PBAF), cause various neurodevelopmental conditions. Although BAF activity ...

Migraine drug flunarizine reversed abnormal microRNA patterns in SMA cells and mice, indicating the drug may help protect ...

Neurosurgeons achieve first-in-human implant of Paradromics' wireless Connexus BCI to restore speech in ALS patient.

Scientists have identified previously unknown neural modules in the brain that control movement and adapt during skill learning. Their findings challenge long-held ideas about how the brain organizes ...

SMA type 2, previously known as Dubowitz disease, is a hereditary disease that affects motor neurons. It typically becomes noticeable around the ages of 6 to 18 months, when children with the ...

SMA type 3 is a hereditary disease that affects motor neurons. People may also refer to it as Kugelberg-Welander disease. Symptoms usually begin after 18 months of age. Children with SMA type 3 can ...